The presence of estrogen and progesterone receptors in uterine carcinosarcoma is associated with improved survival and increased immunogenicity | Caris Life Sciences
Home / Research / Publications / The presence of estrogen and progesterone receptors in uterine carcinosarcoma is associated with improved survival and increased immunogenicity

Publications

The presence of estrogen and progesterone receptors in uterine carcinosarcoma is associated with improved survival and increased immunogenicity

Background: Recent data has shed light on molecular profiles of uterine carcinosarcoma (UCS), but few have correlated molecular profiles with prognosis. In a preliminary data analysis, we found that hormone receptors (HR)—estrogen receptor (ER) and progesterone receptor (PR)—expression was associated with improved OS. Here, we investigate the molecular profile differences between ER+/- and PR +/- tumors.

Download Publication
Learn More
Name(Required)